<International Circulation>: Combination therapy may be an important concept in developing more effective strategies to treat and prevent atherosclerosis and coronary heart disease. Combination therapy with statins， PPARS (peroxisome proliferators-activated receptor agonists)， and RAAS (renin-angiotensin-aldosterone system) blockers demonstrate additive beneficial effects. What is the current thinking on the relationship between PPARs and RAAS as presented at this meeting?

用 户 登 录
用户名：	忘记密码？
密码：	实名认证？
验证码：
只有注册会员才能免费浏览下载幻灯/视频，请登录或注册无法登陆请点击常见问题或与管理员联系

评论发言